Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +13.35%
#3 aelf aelf +9.22%
#4 Gas Gas +5.60%
#5 Tornado Cash Tornado Cash +5.29%
#6 BCGame Coin BCGame Coin +4.98%
#7 B3 (Base) B3 (Base) +4.39%
#8 Fake World Assets Fake World Assets +4.11%
#9 The Black Bull The Black Bull +3.94%
#10 aPriori aPriori +3.79%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Rank in Stocks #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Share Price
$15.31
Last synced: 2024-02-29
Market Cap
$45.70M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Icosavax, Inc. (ICVX)

Category

Healthcare
Stock price history for Icosavax, Inc. (ICVX)
Highest end of day price: $15.31 on 2024-02-01

Lowest end of day price: $29.91 on 2021-07-01
Stock price history of Icosavax, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2024 10.83%
2023 104.14%
2022 -70.48%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -16.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US